Metraipolis › archive › dc_89ccef37267c

Subcutaneous natalizumab administration in relapsing-remitting multiple sclerosis: results of EASIER 2 study — Europe PMC PMID:42429976

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42429976
DOI
10.1007/s00415-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-10-08T05:38:59.595Z
SHA-256 of the archived text
650228e8732e31f42695dc3bdd2fc4532153741c8d6fd4818760f9fad3d6e47e
Stable URL of this page
https://metraipolis.com/documento/dc_89ccef37267c

How to cite

Subcutaneous natalizumab administration in relapsing-remitting multiple sclerosis: results of EASIER 2 study — Europe PMC PMID:42429976 — Europe PMC (en), https://europepmc.org/article/MED/42429976 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_89ccef37267c (Metraipolis archive dc_89ccef37267c, sha256 650228e8732e31f42695dc3bdd2fc4532153741c8d6fd4818760f9fad3d6e47e)
BibTeX
@misc{dc89ccef37267c,
  title = {Subcutaneous natalizumab administration in relapsing-remitting multiple sclerosis: results of EASIER 2 study — Europe PMC PMID:42429976},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42429976},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_89ccef37267c; sha256 650228e8732e31f42695dc3bdd2fc4532153741c8d6fd4818760f9fad3d6e47e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42429976. Agents can read the archived copy with the MCP tool read_document.